This paper is in the following e-collection/theme issue:

Non-randomized Protocols and Methods (ehealth) (568) mHealth for Symptom and Disease Monitoring, Chronic Disease Management (1404) Usability of Apps and User Perceptions of mHealth (979) Patient-Reported Outcome Measures (PROMs) (289) Neurology and Neurosciences (185) Design and Formative Evaluation of Mobile Apps (699)

Published on in Vol 10, No 5 (2021): May

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/25011, first published .
The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study

The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study

The Smartphone App haMSter for Tracking Patient-Reported Outcomes in People With Multiple Sclerosis: Protocol for a Pilot Study

Authors of this article:

Patrick Altmann1 Author Orcid Image ;   Werner Hinterberger2 Author Orcid Image ;   Fritz Leutmezer1 Author Orcid Image ;   Markus Ponleitner1 Author Orcid Image ;   Tobias Monschein1 Author Orcid Image ;   Tobias Zrzavy1 Author Orcid Image ;   Gudrun Zulehner1 Author Orcid Image ;   Barbara Kornek1 Author Orcid Image ;   Rupert Lanzenberger3 Author Orcid Image ;   Klaus Berek4 Author Orcid Image ;   Paulus Stefan Rommer1 Author Orcid Image ;   Thomas Berger1 Author Orcid Image ;   Gabriel Bsteh1 Author Orcid Image
Article Authors Cited by (4) Tweetations (4) Metrics

Journals

  1. Graf B, Altmann P, Löffler-Stastka H. Die subjektive Verarbeitung chronischer Symptome und Schmerz bei Menschen mit Multipler Sklerose: Visualisierung und Externalisierung als Ausdruck der Lebensqualität. psychopraxis. neuropraxis 2022;25(2):107 View
  2. Altmann P, Ponleitner M, Monschein T, Krajnc N, Zulehner G, Zrzavy T, Leutmezer F, Rommer P, Kornek B, Berger T, Bsteh G. Feasibility of a smartphone app to monitor patient reported outcomes in multiple sclerosis: The haMSter interventional trial. DIGITAL HEALTH 2022;8:205520762211353 View
  3. Altmann P, Leutmezer F, Ponleitner M, Ivkic D, Krajnc N, Rommer P, Berger T, Bsteh G. Remote visits for people with multiple sclerosis during the COVID-19 pandemic in Austria: The TELE MS randomized controlled trial. DIGITAL HEALTH 2022;8:205520762211121 View
  4. Greene N, Quéré S, Bury D, Mazerolle F, M’Hari M, Loubert A, Regnault A, Higuchi K. Establishing clinically meaningful within-individual improvement thresholds for eight patient-reported outcome measures in people with relapsing-remitting multiple sclerosis. Journal of Patient-Reported Outcomes 2023;7(1) View